NEUROPACE, INC. Interest Expense
NEUROPACE, INC. (NPCE) reported Interest Expense of $2.26 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-08
- NEUROPACE, INC. interest expense for the quarter ending 2024-03-31 was $2.26M, a 14.91% increase year-over-year.
- NEUROPACE, INC. interest expense for the quarter ending 2023-12-31 was $2.24M, a 15.20% increase year-over-year.
- NEUROPACE, INC. interest expense for the quarter ending 2023-09-30 was $2.19M, a 14.95% increase year-over-year.
- NEUROPACE, INC. interest expense for the quarter ending 2023-06-30 was $2.13M, a 14.74% increase year-over-year.
- NEUROPACE, INC. interest expense for fiscal 2023 was $8.52M, a 13.12% increase from fiscal 2022.
- NEUROPACE, INC. interest expense for fiscal 2022 was $7.53M, a 1.61% increase from fiscal 2021.
- NEUROPACE, INC. interest expense for fiscal 2021 was $7.41M, a 35.49% decline from fiscal 2020.
- NEUROPACE, INC. interest expense for fiscal 2020 was $11.49M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $2.26M 10-Q · filed 2024-05-08 | $4.49M derived: sum of 2 quarters · filed 2024-05-08 | $6.68M derived: sum of 3 quarters · filed 2024-05-08 | $8.81M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $4.43M derived: sum of 2 quarters · filed 2024-03-05 | $6.55M derived: sum of 3 quarters · filed 2024-03-05 | $8.52M 10-K · filed 2024-03-05 |
| 2023-09-30 | $2.19M 10-Q · filed 2023-11-06 | $4.32M derived: sum of 2 quarters · filed 2023-11-06 | $6.28M 10-Q · filed 2023-11-06 | $8.22M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | $2.13M 10-Q · filed 2023-08-08 | $4.09M 10-Q · filed 2023-08-08 | $6.03M derived: sum of 3 quarters · filed 2024-05-08 | $7.94M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $1.97M 10-Q · filed 2024-05-08 | $3.91M derived: sum of 2 quarters · filed 2024-05-08 | $5.81M derived: sum of 3 quarters · filed 2024-05-08 | $7.66M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $3.85M derived: sum of 2 quarters · filed 2024-03-05 | $5.70M derived: sum of 3 quarters · filed 2024-03-05 | $7.53M 10-K · filed 2024-03-05 |
| 2022-09-30 | $1.91M 10-Q · filed 2023-11-06 | $3.76M derived: sum of 2 quarters · filed 2023-11-06 | $5.59M 10-Q · filed 2023-11-06 | $7.45M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $1.85M 10-Q · filed 2023-08-08 | $3.68M 10-Q · filed 2023-08-08 | $5.54M derived: sum of 3 quarters · filed 2023-08-08 | $7.37M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.83M 10-Q · filed 2023-05-04 | $3.69M derived: sum of 2 quarters · filed 2023-05-04 | $5.52M derived: sum of 3 quarters · filed 2023-05-04 | $7.39M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $3.69M derived: sum of 2 quarters · filed 2023-03-02 | $5.56M derived: sum of 3 quarters · filed 2023-03-02 | $7.41M 10-K · filed 2023-03-02 |
| 2021-09-30 | $1.83M 10-Q · filed 2022-11-08 | $3.70M derived: sum of 2 quarters · filed 2022-11-08 | $5.55M 10-Q · filed 2022-11-08 | $7.43M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.87M 10-Q · filed 2022-08-11 | $3.72M 10-Q · filed 2022-08-11 | $5.61M derived: sum of 3 quarters · filed 2022-08-11 | $8.40M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.85M 10-Q · filed 2022-05-12 | $3.73M derived: sum of 2 quarters · filed 2022-05-12 | $6.52M derived: sum of 3 quarters · filed 2022-05-12 | $10.34M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $4.67M derived: sum of 2 quarters · filed 2022-03-10 | $8.49M derived: sum of 3 quarters · filed 2022-03-10 | $11.49M 10-K · filed 2022-03-10 |
| 2020-09-30 | $2.79M 10-Q · filed 2021-11-10 | $6.61M derived: sum of 2 quarters · filed 2021-11-10 | $9.60M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $3.81M 10-Q · filed 2021-08-12 | $6.81M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $3.00M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |